Veeva Systems intends to unveil its vision for "agentic biopharma" during the two-day conference, highlighting the deployment of its new Falcon and Vault AI platforms. These tools are designed to integrate clinical, regulatory, and safety data into a unified ecosystem. The summit agenda includes over 100 sessions focused on practical applications of these technologies across the global life sciences sector.
Veeva Summit to Spotlight AI Transformation in Drug Development
More than 2,500 industry professionals will gather in Boston on October 20-21 for the Veeva R&D and Quality Summit to examine how emerging AI technologies are reshaping pharmaceutical operations. The event features high-profile case studies from major biopharmas aiming to accelerate drug discovery and streamline manufacturing through automation.
Industry leaders are scheduled to detail their specific operational shifts. Eli Lilly and Company will discuss its efforts to boost workforce productivity and submission speed through AI, while UCB plans to share its approach to automating safety case processing. On the clinical front, Duke University and the University of Pennsylvania will examine site-centric strategies using direct data transfers from electronic health records to clinical systems. Meanwhile, Pfizer is set to present findings from its pilot of cloud-based laboratory information management systems, emphasizing the push toward digitized quality control and faster medicine delivery.
Comments (0)
No comments yet. Be the first!